SCHEMBL24254547

SCHEMBL24254547

CN(C)Sc1cccc(NC(=O)Cc2ccc(Cl)c(Cl)c2)c1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
SMN1; SMN2 Q16637 4/20 0.54
MAPT P10636 3/20 0.54
HTT P42858 3/20 0.54
LMNA P02545 3/20 0.54
ALDH1A1 P00352 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.53
STAT3 P40763 1/20 0.51
POLB P06746 1/20 0.50
MAOB P27338 1/20 0.49
KCNJ6 P48051 1/20 0.48
KCNJ5 P48544 1/20 0.48
KCNJ3 P48549 1/20 0.48
ANO1 Q5XXA6 1/20 0.47
NLRP3 Q96P20 1/20 0.47
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24254543 0.88 MEN1 (0.56) MEN1KMT2ASMN1; SMN2MAPTHTT
SCHEMBL24254549 0.86 SMN1; SMN2 (0.67) MEN1KMT2ASMN1; SMN2MAPTHTT
SCHEMBL24254486 0.82 KMT2A (0.62) MEN1KMT2ASMN1; SMN2LMNAALDH1A1
SCHEMBL24254575 0.80 MAPT (0.53) MEN1KMT2ASMN1; SMN2MAPTHTT
SCHEMBL24254515 0.79 MAPT (0.48) MEN1KMT2ASMN1; SMN2MAPTHTT
SCHEMBL8269613 0.79 KMT2A (0.65) MEN1KMT2ASMN1; SMN2MAPTHTT
SCHEMBL24027877 0.78 MEN1 (0.54) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL24254505 0.78 LMNA (0.79) MEN1KMT2ASMN1; SMN2MAPTHTT
SCHEMBL24254508 0.76 MEN1 (0.78) MEN1KMT2ASMN1; SMN2MAPTHTT
SCHEMBL24254506 0.74 KMT2A (0.70) MEN1KMT2ASMN1; SMN2MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035804-A1 SUBSTITUTED 3-AMINO-4-METHYLBENZENESULFONAMIDES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed